Most liposuction devices are FDA-cleared under 510(k), not FDA-approved. The newest clearances include Apyx Medical’s AYON Body Contouring System, cleared May 13, 2025, and expanded May 11, 2026, to add power liposuction. Renuvion, VASERlipo, BodyTite, SmartLipo, and MicroAire PAL systems all hold 510(k) clearances with specific, narrowly worded indications.
What is the difference between an FDA-approved and an FDA-cleared liposuction device?
The two phrases describe different regulatory pathways, and the distinction is not cosmetic. A 510(k) premarket notification asks the FDA to agree that a new device is substantially equivalent to a device already on the market for a stated use. That process ends in a clearance.
Premarket approval (PMA) is the stricter route, generally reserved for higher-risk Class III devices, and requires the manufacturer to submit its own clinical evidence of safety and effectiveness. That process ends in an approval. See the FDA’s own explanation of device approvals and clearances.
Suction lipoplasty systems are Class II devices regulated under 21 CFR 878.5040. Because of that classification, essentially every liposuction platform on the U.S. market reached it through 510(k) clearance. If a website says a liposuction device is “FDA-approved,” the wording is almost certainly wrong.
Which liposuction devices have the newest FDA clearances?
The most recent notable clearance in this category belongs to the AYON Body Contouring System from Apyx Medical. The FDA cleared AYON on May 13, 2025, as a combined platform covering ultrasound-assisted liposuction, electrocoagulation, and Renuvion tissue contraction.
On May 11, 2026, Apyx announced an expanded 510(k) clearance, adding power liposuction to AYON, using a reciprocating cannula. Apyx stated it was beginning a limited commercial launch of that function, so availability in individual practices was still expanding through 2026.
What does Renuvion’s liposuction clearance actually cover?
Renuvion (also sold as J-Plasma in hospital settings) uses radiofrequency energy combined with helium to generate plasma. Its clearance history is unusually well documented, which makes it a useful case study.
Per the FDA’s May 10, 2023, safety communication, three clearances matter here:
- May 25, 2022 (K211652) — Renuvion Dermal Handpiece, for moderate to severe wrinkles and rhytides in patients with Fitzpatrick Skin Types I, II, or III.
- July 15, 2022 (K220970) — Renuvion APR Handpiece, for subcutaneous procedures to improve the appearance of lax skin in the neck and submental region (frequently paired with chin and neck liposuction).
- April 27, 2023 (K230272) — Renuvion APR Handpiece, for coagulation of subcutaneous soft tissues following liposuction for aesthetic body contouring.
That third clearance is the specific one tied to liposuction. Before those clearances existed, the FDA had warned in March 2022 against using Renuvion for dermal resurfacing or skin contraction, because those uses had not been reviewed at the time. The timeline shows how narrow a cleared indication can be.
How do the major FDA-cleared liposuction platforms compare?
|
Device / system |
Technology type |
Regulatory status |
Commonly used for |
|
MicroAire PAL |
Power-assisted (vibrating reciprocating cannula) |
510(k) cleared; suction lipoplasty system |
Larger volumes and dense, fibrous fat |
|
VASERlipo (Solta Medical / Bausch Health) |
Ultrasound-assisted (VASER: Vibration Amplification of Sound Energy at Resonance) |
510(k) cleared, K190551, decision date May 1, 2019, product code QPB |
Fibrous zones such as the male chest and back |
|
AYON Body Contouring System (Apyx Medical) |
Combined ultrasound-assisted and power liposuction plus Renuvion |
510(k) cleared May 13, 2025; expanded clearance May 11, 2026 for power liposuction |
Multi-modality contouring on one platform |
|
SmartLipo / SmartLipo Triplex (Cynosure) |
Laser-assisted lipolysis (1,064 nm Nd: YAG in the original system) |
510(k) cleared in 2006 for laser-assisted lipolysis |
Smaller, defined areas |
|
BodyTite / FaceTite / AccuTite (InMode) |
Bipolar radiofrequency-assisted lipolysis |
510(k) cleared for electrocoagulation and hemostasis in dermatologic and general surgical procedures |
Small to moderate areas with mild laxity |
|
Renuvion APR (Apyx Medical) |
Helium plasma plus radiofrequency |
510(k) cleared April 27, 2023, for coagulation of subcutaneous soft tissues following liposuction |
Adjunct after fat removal |
|
body-jet / Aqualipo (Human Med AG) |
Water-assisted |
510(k) cleared suction lipoplasty system |
Gentler fat harvesting for transfer |
Do energy-assisted devices have FDA clearance for “skin tightening”?
Not usually in those words. InMode’s BodyTite, FaceTite, and AccuTite hold 510(k) clearances framed around electrocoagulation and hemostasis of soft tissue. Skin contraction is a downstream biological effect of controlled heating rather than a phrase that appears in every cleared indication.
Renuvion is the clearest exception, because its APR handpiece carries language about coagulation and contraction of soft tissue. When a consultation includes a skin-tightening promise, ask which specific handpiece and which specific cleared indication that promise rests on.
Does the device matter more than the surgeon?
No. The technology narrows the margin for error; it does not create judgment. Liposuction was the most-performed cosmetic surgical procedure in the United States according to the 2024 ASPS Plastic Surgery Statistics Report, and outcomes across that volume vary far more by operator technique than by brand of cannula.
Dr. Christian Arroyo, a board-certified plastic surgeon in Houston who performs liposuction, selects among these modalities based on fat density, treatment area, and skin quality rather than on which system is newest. Device choice is one input into a surgical plan, not the plan itself.
What should you ask about the device before liposuction?
Ask three questions. First, what is the exact name of the device and handpiece being used? Second, what is its cleared indication for the specific thing you were told it would do? Third, is any part of the planned use off-label, and if so, why is that the recommendation when considering liposuction?
Anyone can verify the answers. The FDA’s 510(k) database is searchable by device name, manufacturer, or K number, and it lists the decision date and indication for each clearance.
Frequently Asked Questions
What does “off-label use” mean for a liposuction device?
Off-label use means a physician uses a cleared device for a purpose outside its FDA-cleared indication. Physicians may legally do this based on clinical judgment, but manufacturers cannot market the device that way. Ask your surgeon directly whether any part of your planned procedure falls outside the device’s cleared indication.
How can I look up a liposuction device’s FDA clearance myself?
Search the FDA 510(k) database by device name, manufacturer, or K number. Each record lists the applicant, decision date, product code, and regulation number, and most link to a PDF summary. That summary contains the indications for use statement, which is the language that actually governs the device.
Is a device cleared in 2026 better than one cleared in 2006?
Not automatically. A 510(k) clearance establishes substantial equivalence to an existing device, not superiority over it. Older platforms such as MicroAire’s power-assisted systems remain widely used because the underlying mechanics work well. Newer clearances often reflect added features or combined modalities rather than better outcomes.
Has the FDA ever issued a safety communication about a liposuction-related device?
Yes. The FDA issued communications about the Renuvion/J-Plasma system in March 2022, June 2022, July 2022, and May 10, 2023, warning against certain aesthetic uses before clearances existed and then documenting each new clearance as it was granted. The FDA states it continues monitoring adverse event reports for minimally invasive soft tissue heating devices.
Is the tumescent fluid used during liposuction FDA-regulated too?
Yes, but as drugs rather than devices. Tumescent solution typically contains lidocaine and epinephrine, both FDA-approved drug products, mixed into saline by the surgical team. The device clearances discussed above cover the cannulas, generators, and handpieces, not the injected solution.
Sources
- FDA — Device Approvals and Clearances: https://www.fda.gov/medical-devices/products-and-medical-procedures/device-approvals-and-clearances
- FDA — UPDATE: Use of Renuvion/J-Plasma Device for Certain Aesthetic Procedures: FDA Safety Communication (May 10, 2023): https://www.fda.gov/medical-devices/safety-communications/update-use-renuvionj-plasma-device-certain-aesthetic-procedures-fda-safety-communication
- FDA — 510(k) Premarket Notification database (searchable): https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm
- FDA — 510(k) record K190551, VASERlipo System, Solta Medical: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K190551
- FDA — 510(k) record K230272, Renuvion APR Handpiece: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K230272
- FDA — 510(k) record K220970, Renuvion APR Handpiece: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K220970
- FDA — 510(k) summary K211652, Renuvion Dermal Handpiece: https://www.accessdata.fda.gov/cdrh_docs/pdf21/K211652.pdf
- eCFR — 21 CFR 878.5040, Suction lipoplasty system: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-H/part-878/subpart-E/section-878.5040
- Apyx Medical — Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System (May 11, 2026): https://apyxmedical.com/apyx-medical-corporation-receives-expanded-fda-510k-clearance-adding-power-liposuction-capability-to-ayon-body-contouring-system/
- Apyx Medical — Receives FDA Clearance for the AYON Body Contouring System (May 13, 2025): https://www.globenewswire.com/news-release/2025/05/13/3080032/0/en/Apyx-Medical-Corporation-Receives-FDA-Clearance-for-the-AYON-Body-Contouring-System.html
- Apyx Medical — 510(k) Clearance for Renuvion for Coagulation of Subcutaneous Soft Tissues Following Liposuction (April 28, 2023): https://apyxmedical.com/apyx-medical-corporation-receives-fda-510k-clearance-for-the-use-of-renuvion-for-coagulation-of-subcutaneous-soft-tissues-following-liposuction-for-aesthetic-body-contouring/
- Cynosure — Smartlipo Triplex product page: https://www.cynosure.com/product/smartlipo-triplex/
- Cynosure — FDA 510(k) Clearance for Cellulaze Cellulite Laser Workstation (January 30, 2012): https://www.prnewswire.com/news-releases/cynosure-receives-fda-510k-clearance-for-cellulaze-cellulite-laser-workstation-138315834.html
- Solta Medical — VASERlipo: https://www.vaser.com/
- MicroAire — PAL Power-Assisted Liposuction System: https://www.microaire.com/
- Human Med AG — body-jet: https://www.humanmed.com/en/products/body-jet/
- American Society of Plastic Surgeons — 2024 Plastic Surgery Statistics Report: https://www.plasticsurgery.org/documents/news/statistics/2024/plastic-surgery-statistics-report-2024.pdf
- Aesthetic Surgery Journal Open Forum — The Safety of Contraction of Subcutaneous Tissue Following Liposuction Procedures: https://pmc.ncbi.nlm.nih.gov/articles/PMC11181943/
